Benign neoplasm: Stomach

CD2_BENIGN_STOMACH

gastric carcinoma: A carcinoma that arises from epithelial cells of the stomach.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D13.1& Hospital discharge: ICD-9 — 2111 Hospital discharge: ICD-8 — 2111 Cause of death: ICD-10 — D13.1& Cause of death: ICD-9 — 2111 Cause of death: ICD-8 — 2111 2 out of 7 registries used, show all original rules.	3700
4. Check minimum number of events None	3700
5. Include endpoints None	3700
6. Filter based on genotype QC (FinnGen only)	3700

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D13
Name in latin: Neoplasma benignum ventriculi

NAME	CD2_BENIGN_STOMACH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D131
HD_ICD_9	2111
HD_ICD_8	2111
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D131
COD_ICD_9	2111
COD_ICD_8	2111
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Stomach based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Stomach

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19792	12427	7254
Only index persons	17931	11514	6417
Unadjusted period prevalence (%)
Whole population	0.30	0.36	0.20
Only index persons	0.36	0.42	0.24
Median age at first event (years)
Whole population	65.96	65.50	66.71
Only index persons	65.31	64.86	66.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3700	2383	1317
Unadjusted period prevalence (%)	0.73	0.81	0.58
Median age at first event (years)	64.38	62.96	66.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3330: Matched controls
33300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

22.3

323.0

2834

6795

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4503599627370496.0

323.0

3253

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

182.5

273.9

284

UJF32

NOMESCO Finland

Coloscopy

3.6

238.7

1502

6165

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.7

166.5

633

1573

A02BC05

ATC

esomeprazole; systemic

2.7

162.5

1819

10194

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

32.2

152.0

203

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.0

148.3

677

1987

A02BC02

ATC

pantoprazole; systemic

2.7

138.4

2537

18045

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.9

130.8

620

1862

A02BC03

ATC

lansoprazole; oral

2.5

122.6

1346

7077

K29.4

ICD-10 Finland

Chronic atrophic gastritis

8.7

113.5

256

315

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.1

108.5

467

1272

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

16.1

92.6

153

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

87.4

1355

8046

B03BA03

ATC

hydroxocobalamin; parenteral

3.9

84.3

378

1056

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

18.1

79.9

126

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

9.1

79.0

172

198

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

77.5

565

2253

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

77.4

849

4244

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

75.8

1661

11144

A02BC01

ATC

omeprazole; systemic

2.1

73.5

1132

6574

UJD02

NOMESCO Finland

Gastroscopy

4.1

73.2

310

819

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

73.2

709

3315

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

4.0

72.9

317

858

K30

ICD-10 Finland

Functional dyspepsia

2.9

71.8

502

1941

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

70.0

508

2007

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

67.8

457

1721

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

67.3

861

4577

107

Kela drug reimbursment

Pernicious anaemia

6.2

65.7

185

313

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

64.9

1026

5953

B81

ICPC

Anaemia vit B12/folate deficiency

4.1

61.1

256

667

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

58.9

412

1582

A02BA02

ATC

ranitidine; systemic

2.1

57.5

835

4637

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

21.3

54.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

53.8

548

2584

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

51.7

474

2113

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

51.5

1039

6491

JDA63

NOMESCO Finland

Local excision of lesion of stomach

40.8

51.1

A02BC04

ATC

rabeprazole; oral

2.6

47.9

374

1523

Z2221

NOMESCO Finland

Medical doctor

1.8

47.2

992

6245

WX002

NOMESCO Finland

Sedation and analgesia

1.9

46.5

795

4644

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

45.4

1383

9754

R06.0

ICD-10 Finland

Dyspnoea

1.8

44.9

924

5754

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

44.8

778

4564

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.2

44.7

253

837

N02BE01

ATC

paracetamol; systemic, rectal

2.0

42.4

2897

25694

UJF92

NOMESCO Finland

Capsular endoscopy

5.4

41.2

128

245

21110

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Stomach

+∞

40.7

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.9

39.4

169

449

8936/1-C16.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of stomach, NOS

65.1

39.1

B01AB05

ATC

enoxaparin; parenteral

1.7

38.6

1108

7580

R03AC02

ATC

salbutamol; inhalant

1.6

38.0

1697

13063

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

37.9

174

490

N02AX02

ATC

tramadol; systemic, rectal

1.6

37.8

1449

10714

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

37.4

642

3718

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

14.0

36.1

K22.1

ICD-10 Finland

Ulcer of oesophagus

5.1

36.0

116

232

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

187.0

35.8

K29.7

ICD-10 Finland

Gastritis, unspecified

3.4

35.6

182

558

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

10.5

35.5

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

16.7

35.0

SPAT1263

SPAT

Sampling

1.6

34.7

1403

10441

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

34.6

758

4749

R01AD09

ATC

mometasone; nasal

1.6

34.0

1398

10432

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

33.5

1247

9064

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

32.9

1221

8852

R13

ICD-10 Finland

Dysphagia

2.5

32.9

278

1177

C07AB07

ATC

bisoprolol; oral

1.6

32.6

1646

12859

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

32.2

196

681

J02AC01

ATC

fluconazole; systemic

1.6

32.2

1310

9706

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

32.2

653

3979

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

31.7

432

2279

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.4

31.7

160

486

K92.1

ICD-10 Finland

Melaena

2.7

31.6

227

876

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

31.5

315

1451

AA1AD

NOMESCO Finland

CT of head and brain

1.7

31.3

837

5544

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

20.7

30.4

K22.7

ICD-10 Finland

Barrett oesophagus

5.8

30.0

154

N03AX16

ATC

pregabalin; oral

1.7

29.8

821

5471

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

17.9

29.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

29.6

2015

16692

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

29.3

505

2907

R03DC03

ATC

montelukast; oral

1.8

29.1

522

3043

Z3226

NOMESCO Finland

Physiotherapist

1.7

28.9

652

4093

J01MA02

ATC

ciprofloxacin; systemic

1.5

28.5

1272

9545

D02

ICPC

Abdominal pain epigastric

2.6

27.8

218

883

A03FA02

ATC

cisapride; oral, rectal

2.1

27.7

323

1592

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.7

27.6

197

758

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.8

27.3

118

316

R4110

NOMESCO Finland

Physiotherapy

1.6

27.2

903

6296

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

27.0

1421

11029

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

26.8

1045

7572

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

26.7

683

4432

C03CA01

ATC

furosemide; systemic

1.6

26.6

1010

7268

D01

ICPC

Abdominal pain/cramps general

2.1

26.6

337

1719

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

26.3

545

3321

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

26.3

274

1283

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

25.9

472

2757

R12

ICD-10 Finland

Heartburn

2.3

25.8

261

1206

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

25.7

635

4076

H02AB06

ATC

prednisolone; systemic

1.5

25.5

1505

11919

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

25.3

158

559

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

8.8

25.2

C03DA01

ATC

spironolactone; oral

1.9

25.2

393

2176

M79.6

ICD-10 Finland

Pain in limb

1.5

25.1

1152

8635

J01DB01

ATC

cefalexin; oral

1.6

25.1

2583

22973

G47.3

ICD-10 Finland

Sleep apnoea

1.7

24.9

648

4215

N06AX11

ATC

mirtazapine; oral

1.5

24.7

1021

7468

ICD-10 Finland

3.6

24.6

114

325

J45

ICD-10 Finland

Asthma

2.0

24.3

330

1732

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

24.2

248

1152

G44.2

ICD-10 Finland

Tension-type headache

1.8

24.2

431

2497

R53

ICD-10 Finland

Malaise and fatigue

1.6

23.9

657

4333

E66.8

ICD-10 Finland

Other obesity

2.6

23.8

181

723

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

47.0

23.3

ZX120

NOMESCO Finland

Intravenous

2.0

23.3

336

1801

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.7

23.1

165

635

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.2

22.9

121

382

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

22.7

306

1598

N03AX12

ATC

gabapentin; oral

1.7

22.7

524

3289

R51.80

ICD-10 Finland

Headache

1.8

22.6

440

2618

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.7

22.6

115

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.4

1348

10620

R11

ICD-10 Finland

Nausea and vomiting

2.1

22.3

276

1392

M25.5

ICD-10 Finland

Pain in joint

1.5

22.2

870

6253

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

22.2

255

1248

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

6.2

22.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.5

22.1

173

702

R03BA02

ATC

budesonide; inhalant

1.7

22.0

556

3579

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

21.8

380

2179

M54.5

ICD-10 Finland

Low back pain

1.5

21.7

1002

7459

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

38.9

21.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

21.7

851

6117

R03AC03

ATC

terbutaline; inhalant

1.7

21.6

447

2710

R01AD08

ATC

fluticasone; nasal

1.5

21.3

843

6064

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

21.2

194

852

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.7

21.1

260

Z3231

NOMESCO Finland

Registered nurse

1.5

21.1

875

6358

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

20.9

298

1591

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

20.7

524

3369

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

20.7

327

1812

SPAT1312

SPAT

General health counselling

1.5

20.7

962

7158

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

20.7

581

3841

WX110

NOMESCO Finland

Local anesthesy

1.4

20.5

2045

17605

JN4BD

NOMESCO Finland

Extensive body CT

1.8

20.4

392

2319

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

20.4

1120

8619

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

20.2

252

1274

J01AA02

ATC

doxycycline; systemic

1.5

20.2

2503

22424

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

20.2

764

5425

R03BA08

ATC

ciclesonide; inhalant

2.0

20.0

271

1415

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

5.6

19.9

105

R05

ICD-10 Finland

Cough

1.6

19.8

621

4216

E0000UV

ATC

1.4

19.8

1190

9306

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

19.5

334

1902

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

19.4

1602

13261

ZXE00

NOMESCO Finland

One hour or less

1.4

19.4

1205

9475

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

19.3

260

1359

XF404

NOMESCO Finland

Ambulatory ECG

1.9

19.1

316

1777

J01FA06

ATC

roxithromycin; oral

1.4

19.1

1269

10094

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

6.3

18.9

2111X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Stomach[NEOPLASMA BENIGNUM ALIUD VENTRICULI]

+∞

18.8

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

18.6

347

2035

SPAT1301

SPAT

No procedures

1.4

18.5

1005

7679

H02AB07

ATC

prednisone; oral

1.7

18.5

469

3008

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

18.5

550

3677

J01CA04

ATC

amoxicillin; systemic

1.4

18.3

2456

22059

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

18.2

220

1100

SPAT1254

SPAT

Administration of medicine

1.6

18.2

464

2982

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

18.1

717

5128

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

18.1

451

2881

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.1

18.1

172

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

18.1

131

509

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

18.1

551

3710

Z01.7

ICD-10 Finland

Laboratory examination

1.8

18.0

359

2146

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

52.8

17.9

R42

ICD-10 Finland

Dizziness and giddiness

1.5

17.9

708

5060

M01AC06

ATC

meloxicam; systemic, rectal

1.4

17.9

1177

9313

JAH01

NOMESCO Finland

Laparoscopy

2.4

17.8

149

625

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

17.7

507

3355

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.7

1179

9343

L04AX01

ATC

azathioprine; systemic

2.5

17.7

146

611

R06AE07

ATC

cetirizine; oral

1.4

17.7

1265

10156

C08CA01

ATC

amlodipine; oral

1.4

17.6

1182

9378

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

17.6

933

7084

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

17.5

252

1349

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

17.5

545

3682

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.5

2022

17597

R06AX27

ATC

desloratadine; oral

1.5

17.5

731

5287

L03

ICPC

Low back symptom/complaint

1.5

17.4

730

5282

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

17.4

753

5484

M03BX02

ATC

tizanidine; oral

1.4

17.4

1836

15730

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

17.4

658

4658

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.9

17.4

107

378

C09CA01

ATC

losartan; oral

1.5

17.3

788

5799

R03BA05

ATC

fluticasone; inhalant

1.6

17.3

534

3604

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

16.0

17.0

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

16.9

153

671

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

16.9

952

7304

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

16.8

519

3496

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

16.8

735

5361

A07AA02

ATC

nystatin; oral

2.0

16.8

236

1252

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

16.7

386

2411

A11

ICPC

Chest pain NOS

1.9

16.7

259

1425

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

16.6

273

1532

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

16.6

694

5013

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

16.6

1488

12370

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

16.5

278

1573

H02AB04

ATC

methylprednisolone; systemic

1.6

16.5

465

3062

Z2446

NOMESCO Finland

Social worker

2.1

16.5

196

974

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

16.5

1784

15286

R4190

NOMESCO Finland

Nutritional therapy

2.7

16.3

110

412

WX892

NOMESCO Finland

Monitored bed care

1.9

16.2

249

1362

B80

ICPC

Iron deficiency anaemia

3.4

16.2

237

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

16.2

362

2238

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

16.2

355

2184

J01FA10

ATC

azithromycin; systemic

1.4

16.2

1659

14071

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

16.1

204

1039

B82

ICPC

Anaemia other/unspecified

2.9

16.1

333

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

16.0

159

730

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

15.9

171

811

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.9

15.8

341

XF402

NOMESCO Finland

ECG with work load test

1.7

15.8

371

2327

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

15.8

303

1788

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

15.8

412

2657

B01AA03

ATC

warfarin; systemic

1.5

15.7

638

4573

C08CA02

ATC

felodipine; oral

1.7

15.6

320

1926

3AC01

NOMESCO Finland

4.6

15.6

120

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

15.5

584

4112

J01DA01

ATC

[U] cefalexin; systemic

1.3

15.5

1905

16573

ZXD05

NOMESCO Finland

Urgent procedure

1.4

15.3

885

6792

K92.0

ICD-10 Finland

Haematemesis

2.9

15.3

324

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

15.1

372

2359

A02BA04

ATC

nizatidine; systemic

1.8

15.1

271

1563

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

15.0

469

3166

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

15.0

331

189

Kela drug reimbursment

Imatinib

10.8

15.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

15.0

122

508

SPAT1255

SPAT

Intravenous administration of medicine

1.9

14.8

219

1184

D03

ICPC

Heartburn

2.6

14.8

112

448

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

14.8

236

1311

JDC97

NOMESCO Finland

Laparoscopic partial gastrectomy with other reconstruction

56.9

14.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.8

1440

12051

N05CF01

ATC

zopiclone; oral

1.4

14.7

1030

8168

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

14.6

242

1362

UJH02

NOMESCO Finland

Anoscopy

2.2

14.6

152

711

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

14.6

820

6253

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

14.6

134

593

H03AA01

ATC

levothyroxine sodium; systemic

1.4

14.5

753

5657

C05AA08

ATC

fluocortolone; rectal, topical

1.6

14.5

449

3022

C10AC01

ATC

colestyramine; oral

2.6

14.4

105

410

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.4

1586

13498

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

14.4

811

6186

M02AA07

ATC

piroxicam; topical

1.4

14.4

1170

9503

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

14.4

328

2039

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

14.3

310

1897

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

14.3

345

2178

SPAT1260

SPAT

Consultation of another employee

1.5

14.2

552

3907

A10AE04

ATC

insulin glargine; parenteral

1.7

14.2

279

1659

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

9.7

14.2

C07AA05

ATC

propranolol; systemic

1.5

14.2

554

3930

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

14.1

163

799

M01AH05

ATC

etoricoxib; oral

1.3

14.1

1742

15064

P01AB01

ATC

metronidazole; oral, rectal

1.3

14.1

1189

9707

K02.1

ICD-10 Finland

Caries of dentine

1.3

14.1

1528

12962

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

14.0

141

652

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.3

14.0

221

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

1591

4486

5.47

307.65

1.7

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1578

8240

2.60

167.01

3.4

2.2

mg/l

3.5

3.1

7.23

1373

6996

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2095

12803

2.47

153.92

4.5

2.8

ug/l

107.5

135.1

5.63

1948

11695

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2503

17068

2.44

136.80

7.4

6.2

umol/l

11.4

11.3

0.16

2368

16167

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2155

13844

2.33

134.10

2.5

2.0

pmol/l

93.7

95.2

0.55

1163

6904

(3024561) Albumin [Mass/volume] in Serum or Plasma

2204

14437

2.30

128.90

6.3

4.7

g/l

35.4

35.2

1.14

2054

13359

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1683

10194

2.19

114.96

3.3

2.6

u/l

55.9

58.0

1.51

1560

9355

(3001604) Monocytes [#/volume] in Blood

2271

15497

2.21

114.13

7.4

5.8

e9/l

0.6

2.06

2007

13238

(3006315) Basophils [#/volume] in Blood

2277

15573

2.20

113.52

7.5

5.8

e9/l

0.0

0.26

2015

13308

(3022948) Iron [Moles/volume] in Serum or Plasma

1024

5112

2.39

110.80

3.3

2.5

umol/l

11.5

12.6

6.55

947

4718

(3019198) Lymphocytes [#/volume] in Blood

2299

15893

2.18

109.99

7.5

5.8

e9/l

1.8

1.9

2.64

2063

13856

(3013115) Eosinophils [#/volume] in Blood

2319

16096

2.18

109.66

7.8

6.0

e9/l

0.2

0.04

2089

13998

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3142

24881

2.74

107.64

10.3

7.7

u/l

82.1

79.4

1.86

2997

23318

(3019309) Folate [Moles/volume] in Red Blood Cells

1193

6551

2.21

101.42

1.9

1.8

nmol/l

1218.0

1173.9

0.73

927

4908

(3004789) Transferrin [Mass/volume] in Serum or Plasma

935

4727

2.31

96.40

3.3

2.5

g/l

2.4

2.3

6.26

871

4361

(3027945) Reticulocytes/100 erythrocytes in Blood

800

3838

2.38

92.70

2.5

1.8

0.03

702

3384

(3013650) Neutrophils [#/volume] in Blood by Automated count

2471

18204

2.08

91.61

10.6

9.1

e9/l

4.1

0.05

2203

15834

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

878

4421

2.29

90.70

3.4

2.6

19.5

22.3

7.20

755

3740

(3013707) Erythrocyte sedimentation rate by Westergren method

2961

23570

2.28

87.01

5.4

4.2

mm/h

14.0

13.4

1.22

2755

21678

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1120

6333

2.10

85.69

1.3

1.2

u/ml

1.7

1.5

0.20

291

1644

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2294

16864

1.95

80.29

8.6

6.7

mmol/l

1.2

3.53

2008

14148

(3011397) Hemoglobin [Presence] in Urine by Test strip

1232

7435

1.99

77.16

5.4

3.8

—

(3022145) Colonoscopy Study observation

727

3603

2.27

76.61

1.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2696

21125

2.02

76.06

6.5

4.8

e6/l

82.5

1776.0

4.20

304

(3032080) INR in Blood by Coagulation assay

1929

13583

1.88

74.89

10.8

9.8

inr

1.3

0.14

388

3808

(3048689) Calprotectin [Mass/mass] in Stool

702

3469

2.26

74.28

2.2

2.1

ug/g

132.2

140.0

0.29

551

2684

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2110

15330

1.88

73.76

7.8

5.9

mmol/l

1.2

4.45

1942

13782

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

805

4224

2.16

73.27

12.5

7.1

—

(3015736) pH of Urine

1739

11930

1.86

72.52

5.0

3.7

—

5.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

719

3630

2.22

71.99

3.2

2.6

umol/l

8.4

0.01

628

3160

(3021960) Folate [Moles/volume] in Serum or Plasma

1275

7980

1.91

70.29

1.8

1.6

nmol/l

21.5

20.9

0.51

1118

6724

(42870588) Differential panel, method unspecified - Blood

1592

10792

1.83

67.47

7.1

5.8

—

(40758558) Short blood count panel - Blood

1271

8073

1.87

66.04

8.4

6.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

958

5563

1.97

65.14

1.5

g/l

2.5

0.15

534

3271

(3015377) Calcium [Moles/volume] in Serum or Plasma

1666

11549

1.81

64.76

3.7

3.4

mmol/l

2.3

2.4

3.67

1432

9960

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

607

2998

2.23

63.47

3.0

2.4

u/l

48.0

54.2

0.11

519

2552

(3023520) Reticulocytes [#/volume] in Blood

590

2907

2.22

61.95

2.4

2.6

e9/l

69.5

69.8

0.04

459

2198

(3037467) Urinalysis macro (dipstick) panel - Urine

2699

21773

1.89

61.76

6.1

4.6

—

(3033658) Prothrombin time (PT) actual/Normal

1268

8188

1.83

61.53

5.5

3.8

88.7

89.5

0.52

1240

7976

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

593

2946

2.21

60.94

2.9

2.4

ug/l

5.3

6.8

1.50

519

2554

(3006504) Eosinophils/100 leukocytes in Blood

1967

14556

1.75

59.05

7.8

6.0

2.9

2.8

0.65

1835

13497

(3018418) pH of Serum or Plasma

1480

10103

1.77

58.99

5.3

4.1

7.4

0.74

171

1918

(3019069) Monocytes/100 leukocytes in Blood

1972

14626

1.75

58.51

8.2

6.3

8.7

0.15

1839

13614

(3019150) Specific gravity of Urine by Refractometry

1079

6714

1.86

58.41

6.3

4.4

kg/l

1.0

0.24

141

1020

(3002030) Lymphocytes/100 leukocytes in Blood

1999

14944

1.73

57.09

8.0

6.2

26.7

27.3

1.76

1856

13826

(3022096) Basophils/100 leukocytes in Blood

1916

14169

1.73

56.78

7.8

6.0

0.7

0.04

1787

13143

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

371

1546

2.56

56.69

1.8

1.7

g/l

1.6

0.01

310

1326

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

699

3796

2.04

56.51

4.6

4.2

u/l

234.2

249.8

2.29

648

3575

(3014576) Chloride [Moles/volume] in Serum or Plasma

745

4151

2.00

55.99

7.9

6.5

mmol/l

104.1

104.2

0.20

735

4059

(40761535) Cells panel - Urine sediment

553

2769

2.17

55.34

4.9

3.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1968

14727

1.72

55.28

7.8

5.9

58.2

57.6

1.32

1827

13684

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

415

1852

2.40

54.61

2.7

2.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

606

3171

2.09

53.98

2.8

2.1

g/l

0.2

0.90

560

2960

(3013826) Glucose [Moles/volume] in Serum or Plasma

2402

19058

1.74

53.88

6.4

4.6

mmol/l

6.8

0.68

2284

17942

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

287

1083

2.79

53.35

1.8

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

2042

15559

1.70

52.54

5.4

4.0

estimate

0.0

1.32

230

2803

(36304419) Bacteria [Presence] in Urine

1293

8723

1.74

52.05

3.9

3.1

—

(3035350) Ketones [Presence] in Urine by Test strip

2014

15324

1.69

51.77

5.4

3.9

estimate

0.0

0.00

223

2834

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

914

5574

1.85

51.76

3.2

2.8

e6/l

1.0

1.2

1.19

571

3191

(3021601) Nitrite [Presence] in Urine by Test strip

2017

15363

1.69

51.55

7.0

5.3

estimate

0.0

0.80

239

2861

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1021

6459

1.80

51.18

3.4

3.1

mmol/l

2.4

2.5

2.61

893

5651

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3429

30776

2.56

50.25

23.3

15.5

mg/l

23.1

24.2

1.18

2894

24674

(3003458) Phosphate [Moles/volume] in Serum or Plasma

746

4302

1.92

50.08

6.6

5.7

mmol/l

1.0

0.04

699

3968

(3044889) 12 lead EKG panel

2712

22482

1.77

49.82

5.3

4.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2862

24115

1.82

49.61

5.2

4.2

pmol/l

14.9

0.20

2632

21682

(3030467) Casts [#/volume] in Urine by Automated count

1317

9035

1.71

49.24

4.1

3.2

e6/l

0.5

0.00

1048

6852

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1822

13620

1.67

49.10

2.8

2.3

nmol/l

79.6

79.2

0.20

1597

12056

(3013139) Helicobacter pylori Ag [Presence] in Stool

442

2118

2.23

49.01

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

880

5391

1.83

48.69

3.7

3.2

mmol/l

0.8

0.35

822

5004

(3018095) Leukocytes [#/volume] in Urine

1573

11342

1.67

48.57

5.0

3.8

e6/l

77.5

113.5

0.63

1168

8096

(3014765) Yersinia sp identified in Stool by Organism specific culture

246

907

2.83

47.68

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

899

2.84

47.35

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

246

914

2.81

46.99

1.3

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1427

10127

1.67

46.19

3.8

3.0

ng/l

1395.8

1515.7

0.56

1230

8718

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1402

9913

1.67

45.97

3.9

3.2

u/l

33.1

36.9

1.08

1326

9391

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1432

10210

1.66

45.27

2.4

2.1

u/l

150.2

210.3

3.53

1357

9530

(3000850) Epithelial cells [#/volume] in Urine

1040

6881

1.71

43.26

3.1

2.6

e6/l

4.8

5.8

2.49

899

6023

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3223

28571

1.99

42.90

6.5

5.0

mu/l

1.9

2.1

1.53

2999

25857

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1917

14864

1.60

41.96

4.7

4.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

504

2702

2.00

41.23

4.0

3.7

ng/l

95.5

91.4

0.40

439

2283

(40768804) Tissue Pathology biopsy report

1728

13153

1.59

40.30

2.4

2.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

488

2612

2.00

40.04

3.2

2.7

ml/min/173m2

62.0

62.9

0.11

206

1095

(4010399)

444

2303

2.05

39.74

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

681

4084

1.82

39.42

1.4

1.3

titre

581.6

548.9

0.15

154

889

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1676

12729

1.58

39.03

4.7

3.8

ng/l

31.1

87.0

0.96

1183

9168

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1027

6931

1.67

38.91

2.4

1.7

mg/l

1.1

1.3

0.96

796

5358

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

980

6547

1.68

38.55

4.7

3.8

ng/l

333.5

484.2

0.37

795

5340

(40761511) CBC panel - Blood by Automated count

3456

31693

2.37

38.31

21.9

14.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1191

8389

1.62

37.85

3.4

2.7

umol/l

3532.0

5400.1

0.98

1007

7184

(3004716) Salmonella sp identified in Stool by Organism specific culture

297

1343

2.32

37.49

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1401

10275

1.59

37.49

2.9

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

796

5063

1.73

37.41

3.0

2.1

30.0

29.8

0.34

771

4910

(3009542) Hematocrit [Volume Fraction] of Blood

3070

27099

1.78

37.17

26.1

16.8

38.2

39.0

4.33

1961

18168

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

281

1254

2.34

36.55

3.4

3.2

u/ml

2391.0

3543.5

0.14

233

1055

(3019550) Sodium [Moles/volume] in Serum or Plasma

3491

32240

2.47

36.55

27.4

18.0

mmol/l

139.6

139.7

1.01

3427

31433

(3000570) Elastase.pancreatic [Mass/mass] in Stool

240

999

2.50

36.41

1.5

1.4

ug/g

254.9

275.8

0.89

139

581

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

456

2475

1.96

35.72

1.8

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2335

19333

1.56

35.69

4.0

3.2

u/l

57.6

51.2

1.81

2160

17732

(3023103) Potassium [Moles/volume] in Serum or Plasma

3491

32323

2.42

34.85

27.6

18.2

mmol/l

4.0

7.38

3424

31461

(3002582) Erythrocytes [#/volume] in Urine

1331

9771

1.57

34.78

4.3

3.3

e6/l

79.6

85.0

0.07

1066

7522

(3007853) Bacteria identified in Skin by Aerobe culture

606

3654

1.79

34.00

1.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

1415

10576

1.55

33.88

3.9

3.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

629

3846

1.77

33.61

7.7

6.9

kpa

12.0

12.2

0.43

602

3668

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

629

3846

1.77

33.61

7.7

6.9

kpa

5.0

5.1

1.32

602

3672

(3003396) Base excess in Arterial blood by calculation

626

3825

1.77

33.52

7.7

6.9

mmol/l

1.4

1.2

0.77

513

2985

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

615

3739

1.77

33.50

3.3

4.0

ug/l

4.3

25.3

4.29

490

3029

(3002173) Hemoglobin [Mass/volume] in Arterial blood

537

3145

1.83

33.13

8.3

7.7

g/l

117.3

120.4

3.22

522

3028

(3000991) Gas panel - Venous blood

475

2695

1.87

32.38

9.6

7.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

502

2899

1.85

32.36

2.6

g/l

65.5

66.3

1.32

449

2636

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

123

380

3.31

32.35

3.4

3.2

nmol/l

13.6

19.6

0.16

115

369

(3026782) Osmolality of Urine

937

6427

1.61

32.24

3.5

2.8

mosm/kgh2o

520.3

537.0

1.61

765

5467

(3021589) Normoblasts [#/volume] in Blood

1744

13736

1.51

32.14

11.7

9.9

e9/l

0.0

1.42

1464

11158

(3020961) Endomysium IgA Ab [Titer] in Serum

272

1269

2.23

31.78

1.1

titre

68.0

198.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

511

3012

1.81

30.71

3.6

2.9

ng/l

209.3

206.8

0.04

457

2747

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

778

5163

1.64

30.35

3.7

2.9

e6/l

2.6

2.7

0.05

443

2799

(3016502) Oxygen saturation in Arterial blood

558

3399

1.76

29.93

8.2

7.3

95.9

95.6

0.48

544

3275

(3014111) Lactate [Moles/volume] in Serum or Plasma

492

2894

1.81

29.72

8.1

6.5

mmol/l

1.3

1.4

0.12

468

2802

(36660697) Celiac disease serology panel - Serum

408

2273

1.89

29.30

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

210

908

2.39

29.27

1.8

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1089

7890

1.54

28.98

2.8

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

638

4088

1.68

28.33

1.5

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

8.30

28.24

1.9

1.4

pmol/l

154.9

26.8

2.51

(3020891) Body temperature

276

1359

2.11

28.09

4.5

4.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

409

2313

1.86

27.98

3.0

2.8

g/l

10.3

10.4

0.31

378

2106

(3003338) MCHC [Mass/volume]

2835

25054

1.56

27.93

33.6

20.3

g/l

329.7

331.4

16.79

2813

24852

(3020779) Urea [Moles/volume] in Serum or Plasma

490

2938

1.77

27.62

9.6

7.2

mmol/l

10.7

10.2

0.73

467

2794

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3188

29026

1.71

27.37

7.9

6.1

mmol/mol

41.2

40.2

6.34

2966

26592

(3009508) Creatinine [Moles/volume] in Urine

1330

10141

1.49

27.36

3.4

3.1

mmol/l

6.8

7.0

1.67

1108

8407

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

280

1408

2.07

26.94

1.1

1.0

—

(3023368) Bacteria identified in Blood by Culture

1211

9086

1.49

26.86

5.0

4.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

689

4559

1.63

26.83

36.2

26.3

inr

1.4

0.14

624

(3012516) Albumin [Mass/volume] in Urine

1296

9882

1.48

26.42

3.6

3.2

mg/l

553.3

344.3

0.70

797

6051

(3017143) Hepatitis C virus Ab [Presence] in Serum

458

2739

1.77

25.97

1.6

1.5

—

(3019060) Gas panel - Arterial blood

389

2217

1.84

25.88

4.6

4.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

498

3055

1.73

25.80

4.6

3.5

kpa

5.8

0.06

483

2967

(3024354) Oxygen [Partial pressure] in Venous blood

427

2508

1.79

25.73

3.9

2.9

kpa

4.5

0.06

413

2427

(3025941) Bacteria identified in Stool by Culture

311

1667

1.95

24.97

1.5

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3481

32709

2.09

24.90

15.8

11.1

u/l

25.6

25.1

0.81

3395

31427

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

590

3822

1.65

24.83

2.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

469

2859

1.73

24.80

2.5

2.2

nmol/l

356.1

373.0

1.12

418

2611

(3008152) Bicarbonate [Moles/volume] in Arterial blood

369

2098

1.84

24.70

7.0

6.7

mmol/l

24.7

24.6

0.18

349

1951

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

769

5326

1.56

24.43

1.3

iu/ml

26.8

35.5

1.25

215

1675

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2012

16854

1.42

23.92

2.8

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

906

6530

1.51

23.88

5.3

4.6

—

(3002032) Base excess in Venous blood by calculation

489

3045

1.70

23.88

4.7

3.6

mmol/l

1.9

2.0

0.51

400

2482

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1475

11689

1.44

23.88

6.0

4.2

—

(3002385) Erythrocyte distribution width [Ratio]

2795

24912

1.50

23.69

28.9

19.0

14.1

13.8

18.50

2754

24339

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

739

5104

1.56

23.68

1.3

1.2

u/ml

16.7

12.8

0.25

263

1911

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3283

30364

1.72

23.66

6.0

4.9

mmol/l

6.1

6.0

3.09

3004

27406

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

481

2995

1.70

23.47

1.6

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

155

4.12

23.18

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

182

824

2.27

22.82

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1332

10424

1.43

22.80

4.3

3.9

mg/mmol

12.0

8.5

1.32

809

6369

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

581

3835

1.61

22.49

2.0

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

334

1919

1.81

21.53

1.6

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

119

459

2.65

21.14

2.0

1.6

g/l

0.7

0.8

0.24

334

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3461

32687

1.91

20.83

27.1

18.3

umol/l

80.6

77.7

4.31

3461

32676

(3004588) Protein electrophoresis panel - Serum or Plasma

401

2460

1.71

20.55

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

111

428

2.64

19.76

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3159

29199

1.56

19.70

4.8

4.1

mmol/l

1.3

3.98

2867

26285

(3007566) Smooth muscle Ab [Titer] in Serum

173

816

2.18

19.64

1.3

1.2

titre

78.6

88.0

0.22

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

224

1170

1.97

19.34

3.3

2.9

u/ml

0.3

0.4

0.19

127

678

(3028026) IgM [Mass/volume] in Serum or Plasma

317

1851

1.78

19.32

1.8

1.9

g/l

1.5

1.4

0.16

289

1675

(3000494) Fungus identified in Specimen by Culture

552

3726

1.57

19.21

1.7

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

765

5540

1.48

19.11

2.1

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

176

857

2.11

18.43

4.5

2.4

g/l

3.6

0.03

169

810

(3029937) Albumin [Presence] in Urine by Test strip

1072

8312

1.41

18.41

6.5

4.4

estimate

0.0

1.28

230

2763

(3000492) Spirometry study

423

2741

1.61

17.42

1.7

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

314

1884

1.73

17.37

1.3

au/ml

50.8

51.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

265

1517

1.80

17.24

4.2

2.5

0.6

0.7

0.33

252

1452

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

149

701

2.17

17.05

1.4

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

264

1517

1.80

16.96

5.7

3.8

mmol/l

24.0

24.3

0.46

232

1360

(3007461) Platelets [#/volume] in Blood

3523

33698

1.95

16.94

36.5

22.9

e9/l

250.0

250.7

0.24

3466

32781

(3024731) MCV [Entitic volume]

3523

33705

1.95

16.82

36.4

22.9

90.7

91.4

17.80

3484

33155

(3035941) MCH [Entitic mass]

3523

33706

1.95

16.80

36.3

22.8

29.9

30.4

30.51

3484

33155

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3229

30203

1.54

16.79

5.3

4.6

mmol/l

1.4

1.5

15.48

2963

27430

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

196

1027

1.96

16.78

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

3523

33709

1.94

16.75

36.6

22.9

e12/l

4.4

7.02

3454

32675

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

313

1895

1.71

16.75

3.6

3.2

pmol/l

4.4

0.09

268

1662

(3010813) Leukocytes [#/volume] in Blood

3523

33712

1.94

16.70

36.6

23.0

e9/l

6.7

0.04

3452

32670

(3000963) Hemoglobin [Mass/volume] in Blood

3523

33717

1.94

16.62

36.8

23.1

g/l

129.9

133.5

39.17

3482

33177

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1038

1.95

16.60

2.4

2.3

g/l

0.0

0.20

174

952

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3310

31149

1.59

16.59

6.2

5.2

mmol/l

2.6

2.7

10.52

3056

28334

(3052851) Hemolysis interference index of Serum or Plasma

194

1019

1.95

16.50

3.7

3.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

265

1551

1.76

15.99

4.2

2.5

1.1

1.2

0.45

265

1540

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

333

2080

1.66

15.84

2.5

2.4

au/ml

9.3

23.8

3.47

(3021879) Hepatitis B virus core Ab [Presence] in Serum

292

1762

1.71

15.81

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3244

30451

1.53

15.75

5.4

4.6

mmol/l

4.5

4.7

19.21

3006

27854

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1187

1.86

15.73

2.4

g/l

0.7

1.0

0.73

181

1025

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

1389

1.79

15.60

2.4

g/l

7.4

7.5

0.05

173

1041

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1300

1.82

15.60

2.4

g/l

3.2

3.1

0.45

170

1020

(46235355) HIV 1 and 2 tests - Meaningful Use set

495

3413

1.52

15.43

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

628

4544

1.46

15.42

2.3

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1387

1.79

15.40

2.4

g/l

3.7

3.8

0.17

169

995

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

703

2.11

15.39

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

703

2.11

15.39

1.4

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

325

2032

1.66

15.39

4.3

3.1

g/l

122.0

127.6

4.45

317

1980

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

211

1168

1.86

15.31

1.1

u/ml

0.8

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

292

1781

1.69

15.19

1.6

1.3

u/ml

144.0

204.0

1.57

274

1627

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1387

1.78

15.12

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

936

7292

1.38

15.08

1.9

1.7

pmol/l

11473732.0

28836636.6

0.73

767

5989

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

290

1772

1.69

14.99

10.7

9.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

182

968

1.93

14.93

2.5

2.3

g/l

0.0

0.00

160

887

(3036489) Thrombin time

202

1121

1.85

14.55

3.1

2.0

22.4

21.5

0.50

182

981

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

179

957

1.91

14.47

2.5

2.3

g/l

0.0

0.00

160

886

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

748

2.03

14.43

1.1

u/ml

11.7

6.9

0.25

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

190

1039

1.87

14.33

1.6

titre

82.9

326.4

—

(3042733) HLA Ab [Presence] in Serum

4.62

14.22

5.8

5.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

162

843

1.96

14.18

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

210

1189

1.81

14.18

1.4

1.2

u/ml

0.9

1.3

0.21

111

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

170

902

1.93

14.06

3.4

2.1

91.9

90.5

0.33

159

848

(44790049)

349

2.50

13.89

1.9

1.4

—

(44806118)

349

2.50

13.89

1.9

1.4

—

(44790047)

349

2.50

13.89

1.9

1.4

—

(44790048)

349

2.50

13.89

1.9

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1291

1.77

13.70

2.4

g/l

10.2

10.3

0.06

181

1091

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

166

887

1.91

13.45

1.5

1.6

g/l

0.2

0.26

155

844

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1092

1.82

13.36

2.4

2.2

g/l

37.2

37.5

0.40

167

934

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

826

1.94

13.33

4.1

2.4

196.2

197.3

0.06

149

787

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

169

918

1.88

13.04

1.6

g/l

1.2

0.21

160

874

(3028192) IgG subclass 2 [Mass/volume] in Serum

291

2.57

12.78

1.8

1.4

g/l

2.8

0.02

197

(3027135) IgG subclass 1 [Mass/volume] in Serum

291

2.57

12.78

1.8

1.4

g/l

6.0

7.0

1.67

198

(3024139) IgG subclass 3 [Mass/volume] in Serum

291

2.57

12.78

1.8

1.4

g/l

0.4

0.54

197

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

392

2.33

12.48

1.1

g/l

1.6

1.5

0.35

352

(3023183) Ammonium ion [Moles/volume] in Plasma

131

673

1.98

11.95

3.8

2.7

umol/l

36.2

34.9

0.17

115

571

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3107

29239

1.39

11.86

20.2

14.6

ml/min/173m2

76.1

76.7

0.80

2623

24274

(3026389) Candida sp identified in Specimen by Organism specific culture

440

2.21

11.82

1.5

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

273

1748

1.61

11.74

10.6

8.8

mmol/l

24.6

24.4

0.73

251

1634

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

435

3083

1.47

11.71

1.6

—

(4035726)

433

3075

1.46

11.53

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

616

4670

1.38

11.35

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

228

2.66

11.14

1.2

titre

336.4

93.9

0.92

(4062490)

293

2.45

11.14

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

336

2.35

11.13

1.6

1.5

—

(40768443) Skin Pathology biopsy report

234

1468

1.63

10.94

1.2

—

(3016038) Potassium [Moles/volume] in Urine

219

2.67

10.91

1.2

1.1

mmol/l

32.2

35.0

0.36

188

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

315

2.38

10.86

1.7

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

192

2.79

10.79

1.3

1.1

u/l

34.4

16.5

1.45

165

(3003181) Sodium [Moles/volume] in Urine

121

631

1.95

10.61

1.3

mmol/l

57.7

61.3

0.59

104

510

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

107

3.39

10.26

2.9

2.1

e6/l

2359.2

24339.3

0.64

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

592

1.96

10.13

11.5

4.8

iu/ml

632.0

642.2

0.01

(3023487) Leukocytes [#/volume] in Peritoneal fluid

123

3.19

10.12

3.1

2.3

e6/l

263.0

932.8

2.10

(3035637) Corticotropin [Mass/volume] in Plasma

380

2.18

9.89

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

215

1356

1.62

9.85

2.0

ug/l

2.7

2.5

0.10

185

1191

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

455

2.05

9.40

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

462

2.04

9.39

3.8

2.4

u/ml

305.4

2044.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

185

1142

1.65

9.25

3.2

2.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.55

9.21

2.2

1.5

g/l

11.1

13.6

0.63

(3017817) Protein [Mass] in Urine collected for unspecified duration

302

2.28

9.12

3.2

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

278

1893

1.51

9.11

1.3

1.2

iu/ml

91.3

154.7

3.58

105

677

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

723

1.81

9.10

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

121

666

1.84

9.06

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

204

1299

1.60

9.01

1.9

1.8

u/l

39.2

39.1

0.03

167

1144

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

490

1.98

9.01

1.3

nmol/l

0.4

0.3

0.05

(3022493) Free Hemoglobin [Mass/volume] in Plasma

122

3.05

8.96

9.4

6.3

mg/l

125.3

62.4

0.48

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

177

2.68

8.95

2.3

2.7

41.6

39.5

0.26

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

487

1.98

8.81

1.3

nmol/l

0.6

0.14

467

(3027273) Bicarbonate [Moles/volume] in Venous blood

245

1636

1.53

8.80

3.2

mmol/l

25.0

25.4

0.91

239

1585

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

454

2.01

8.74

1.6

1.4

u/ml

102.0

120.4

0.63

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

152

908

1.70

8.62

1.5

iu/ml

0.1

7.0

0.58

197

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

128

729

1.78

8.59

1.5

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

522

1.92

8.48

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

453

1.99

8.44

1.3

—

(4094501)

145

864

1.71

8.31

1.1

—

(3002256) Pathology report gross observation

548

4275

1.33

8.22

1.4

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

136

799

1.73

8.21

2.7

2.3

ug/min

129.0

90.5

0.42

480

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

129

747

1.75

8.19

2.4

3.3

u/ml

2745.3

743.8

0.33

115

684

(21494890) Protein electrophoresis panel - 24 hour Urine

364

2.08

8.11

1.9

2.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

199

2.48

8.05

1.1

nmol/l

9.9

6.8

0.17

(1761868) Lipid panel - Serum or Plasma

829

9911

0.79

8.04

3.4

3.0

—

(3024471) HLA-A [Type]

3.44

7.93

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

361

2.07

7.90

1.2

u/l

56.8

59.0

0.14

245

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

564

1.85

7.88

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

276

2.23

7.88

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

4.34

7.67

1.2

1.1

ug/l

100.6

76.5

—

(3024932) HLA-DR beta [Type]

3.44

7.66

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

174

2.55

7.65

1.3

1.6

u/l

6.1

6.6

0.18

146

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

770

1.71

7.65

1.7

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

578

1.82

7.61

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

178

1147

1.58

7.53

3.3

3.4

mg/l

38.6

62.1

1.09

155

935

(40768441) Liver Pathology biopsy report

227

2.31

7.33

1.6

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

173

1116

1.58

7.29

3.3

ratio

1.6

0.02

(3034860) Kappa light chains.free [Mass/volume] in Serum

177

1148

1.57

7.29

3.3

3.4

mg/l

57.5

110.2

0.53

154

934

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

579

1.80

7.27

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

662

1.75

7.21

1.7

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

133

2.72

7.17

37.0

26.0

ug/l

115.1

111.0

0.12

110

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

453

1.90

7.11

1.6

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

139

860

1.64

6.97

3.4

3.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

298

2.10

6.93

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

240

2.23

6.88

1.1

—

(3037756) Immunofixation for Serum or Plasma

124

748

1.68

6.86

1.5

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.12

6.85

1.9

2.6

160.3

180.1

0.59

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

459

1.87

6.85

1.2

u/ml

334.7

289.5

0.80

274

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

474

1.86

6.82

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

148

936

1.61

6.80

1.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

527

1.80

6.73

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

129

791

1.65

6.71

2.0

1.9

mg/l

12.4

11.9

0.31

122

725

(3017732) Neutrophils [#/volume] in Blood

295

2158

1.40

6.65

3.1

3.2

e9/l

4.2

4.1

0.44

208

1627

(3013512) EKG study

1132

9851

1.21

6.63

4.9

4.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

187

2.37

6.62

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

450

1.86

6.62

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

117

2.75

6.53

1.9

2.4

139.2

160.5

0.91

110

(3045683) HLA typing for celiac disease panel - Blood or Tissue

140

2.59

6.52

1.1

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

146

2.55

6.51

2.2

2.4

u/ml

955.9

1501.5

0.59

146

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

279

2.10

6.50

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

279

2.10

6.50

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

279

2.10

6.50

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

228

2.21

6.40

1.0

mg/l

290.7

290.1

0.02

203

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

190

2.33

6.40

1.2

—

(3024928) Oxygen saturation in Venous blood

112

673

1.68

6.31

6.4

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

123

758

1.64

6.30

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

458

1.83

6.28

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

599

1.72

6.25

1.4

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

127

791

1.63

6.24

1.7

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

130

815

1.62

6.22

1.8

1.6

e6/l

10526.5

13249.5

0.57

578

(3044007) Cell count panel - Peritoneal fluid

2.87

6.20

2.9

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

188

2.30

6.10

1.9

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

442

1.83

6.04

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

241

2.13

6.00

1.1

1.2

—

(3004775) Volume in Urine collected for unspecified duration

261

2.08

6.00

2.9

2.2

706.2

628.7

0.88

170

(3027570) Oxalate [Moles/time] in 24 hour Urine

6.26

5.95

2.0

1.3

umol/24h

372.4

364.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

249

2.10

5.92

2.2

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

2.34

5.90

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

2.34

5.90

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

508

1.75

5.76

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

175

2.30

5.68

1.8

2.1

e9/l

0.3

0.2

0.54

154

(3009214) Lutropin [Units/volume] in Serum or Plasma

489

1.76

5.64

1.3

u/l

13.6

13.3

0.05

387

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

610

1.67

5.63

2.5

1.7

nmol/l

0.9

0.8

0.37

502

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

498

1.74

5.58

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

439

1.79

5.58

1.1

—

(3023419) Bacteria identified in Sputum by Culture

434

1.79

5.48

3.4

2.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

464

1.76

5.47

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

204

2.17

5.46

1.8

1.3

u/ml

0.6

1.1

0.47

100

(3017446) Testosterone [Moles/volume] in Serum or Plasma

220

1585

1.41

5.46

2.5

2.1

nmol/l

12.1

12.2

0.05

186

1374

(3016750) Collection duration of Urine

192

2.20

5.40

2.7

2.0

min

497.8

493.3

0.13

139

(3006922) Hepatitis E virus Ab [Presence] in Serum

186

2.22

5.37

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

430

1.78

5.35

1.2

1.3

nmol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

294

1.95

5.34

1.1

—

(21494434) Karyotype in Bone marrow

309

1.92

5.30

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

374

2941

1.30

5.26

1.7

1.5

0.08

311

2527

(3045414) Leukocytes [Presence] in Urine

207

1489

1.41

5.20

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

5.16

2.2

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

305

1.92

5.15

1.4

u/l

33.1

34.4

0.10

245

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

384

1.81

5.15

1.8

1.9

u/l

6460.8

2235.8

0.44

140

(3024891) Influenza virus A+B Ag [Presence] in Specimen

114

728

1.58

5.12

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

110

2.56

5.04

1.8

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

366

1.82

4.99

3.7

3.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

561

1.66

4.99

1.6

1.2

u/l

43.8

41.5

0.06

479

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

194

2.13

4.88

1.9

2.1

e6/l

529.2

668.5

0.74

(3011412) CD3 cells [#/volume] in Blood

283

1.92

4.87

1.8

2.0

e9/l

1.2

1.1

0.61

176

(3011985) Renin [Units/volume] in Plasma

437

1.73

4.82

1.5

1.4

mu/l

39.5

47.1

0.29

382

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.58

4.76

7.7

15.2

mmol/l

4.9

5.3

0.39

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

538

1.65

4.74

1.9

1.6

—

(3049717) Cytology report of Urine Cyto stain

177

1260

1.43

4.74

2.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

252

1.96

4.68

1.1

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

218

2.03

4.66

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

146

2.27

4.63

1.4

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

972

8573

1.18

4.62

1.7

1.6

mmol/l

1.4

0.50

830

7136

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

186

2.11

4.57

1.8

2.0

e6/l

491.9

485.8

0.03

155

(3021788) Differential panel - Synovial fluid

599

1.60

4.54

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

163

1155

1.43

4.49

2.2

ug/l

386.5

654.9

0.75

154

1089

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

792

6878

1.19

4.49

5.1

4.5

22.6

21.8

0.79

437

3508

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

107

696

1.55

4.48

2.1

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

110

720

1.54

4.48

1.6

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.28

4.46

1.4

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

168

2.15

4.46

1.1

iu/ml

6.0

10.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

222

1.99

4.45

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

425

1.71

4.44

1.3

1.2

u/ml

5.1

4.0

0.14

134

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

130

2.32

4.42

4.1

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

345

1.78

4.37

1.1

1.0

u/ml

6.7

3.5

0.29

134

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

129

879

1.48

4.36

1.5

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

606

1.58

4.34

1.2

—

253.8

—

(3051651) Icteric interference index of Serum or Plasma

204

2.02

4.31

3.9

3.7

—

(3033799) Differential panel - Peritoneal fluid

107

2.44

4.29

2.5

2.0

—

(3006270) Folate [Moles/volume] in Blood

296

1.84

4.29

1.4

1.2

nmol/l

365.8

357.4

0.06

250

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

415

1.70

4.27

1.3

1.2

u/ml

6.7

5.0

0.41

178

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

438

1.68

4.26

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

130

1855

0.69

4.20

1.4

—

(3003694) ABO and Rh group [Type] in Blood

880

7754

1.18

4.18

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

636

1.56

4.17

1.4

1.2

u/ml

10.2

3.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

100

653

1.55

4.15

1.3

1.2

mmol/l

3.8

0.42

604

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.60

4.13

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

442

1.66

4.13

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

435

1.67

4.11

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

174

2.08

4.11

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

174

2.08

4.11

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

215

1.96

4.10

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

215

1.96

4.10

2.0

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

134

935

1.45

4.05

1.4

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

224

1.93

4.00

1.8

1.5

u/l

5.6

6.7

0.21

105

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

188

1396

1.37

3.98

4.7

5.2

1.6

0.19

177

1308

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

289

1.81

3.98

5.2

4.6

u/ml

349.4

45.7

0.73

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

447

1.65

3.97

1.3

1.4

—

(3039000) Anion gap in Blood

110

741

1.50

3.97

6.4

7.3

mmol/l

11.1

0.02

100

664

(3018572) Chloride [Moles/volume] in Blood

110

741

1.50

3.97

6.4

7.3

mmol/l

105.2

105.0

0.15

100

664

(44813793)

197

1.99

3.96

1.1

—

(4034850)

1048

0.60

3.96

20.7

10.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

1.94

3.96

1.9

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

219

1.93

3.91

1.7

2.1

17.5

14.4

0.52

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

365

1.71

3.91

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

435

1.64

3.86

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

172

2.04

3.84

2.2

2.1

ug/min

258.0

161.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

407

1.66

3.77

1.3

pmol/l

259.2

276.0

0.24

314

(3005988) Vibrio sp identified in Specimen by Organism specific culture

438

1.63

3.77

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

222

1.90

3.77

1.1

—

(3044927) Protein electrophoresis panel - Urine

377

1.68

3.76

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

185

1384

1.35

3.75

4.8

5.2

0.9

0.40

172

1301

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

962

8602

1.16

3.74

5.7

5.2

ug/l

3.1

3.2

0.05

868

7642

(3017704) Immunofixation for Urine

202

1.94

3.72

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

318

1.74

3.71

2.8

2.9

—

(3047181) Lactate [Moles/volume] in Blood

143

1028

1.41

3.70

6.1

6.4

mmol/l

1.4

1.3

0.19

126

906

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

114

787

1.46

3.67

4.5

2.9

mg/l

1.9

1.6

2.03

106

711

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

189

1.97

3.67

1.9

1.7

—

(40757373) Influenza virus identified in Isolate

2.61

3.63

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.88

3.63

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.88

3.63

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.88

3.63

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

266

2107

1.28

3.60

1.8

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

2.08

3.56

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.45

3.54

1.3

1.4

ug/l

11.8

8.8

1.46

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.18

3.49

1.2

1.3

nmol/l

5.1

239400.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

165

2.01

3.49

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

165

2.01

3.49

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.48

3.46

1.5

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

222

1.86

3.45

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

222

1.86

3.45

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

159

2.02

3.44

1.6

1.3

nmol/l

137.8

136.2

0.08

159

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.10

3.37

1.6

1.5

—

(3006462) Nitrate [Presence] in Urine

156

2.00

3.24

5.3

4.3

—

(3022689) Creatine [Moles/volume] in Urine

2.34

3.24

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.16

3.21

8.2

4.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

157

1.98

3.19

1.1

—

(4211845)

171

1.94

3.18

5.0

4.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

580

1.49

3.16

1.3

1.2

miu/ml

187.4

208.9

0.20

244

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

233

1848

1.28

3.16

3.1

3.9

u/ml

83.5

65.0

0.12

217

1784

(3003888) Timothy IgE Ab [Units/volume] in Serum

327

1.66

3.14

1.1

u/ml

4.5

3.4

0.22

148

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.41

3.13

1.0

1.1

91.0

84.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.38

3.05

1.1

1.3

75.0

82.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.45

3.04

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

1.98

2.99

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

161

1.93

2.99

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

10.01

2.98

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

309

1.66

2.97

1.4

1.3

e6/l

150188.4

92057.1

0.16

208

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.41

2.96

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

249

1.74

2.95

1.9

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

420

1.56

2.93

1.1

—

(3036603) Volume of Urine

214

1.78

2.87

1.6

1.4

1977.9

1756.4

0.40

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

447

1.53

2.85

2.3

2.2

mg/l

29.1

24.8

0.22

106

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

645

1.44

2.81

1.3

e6/l

49.1

27.9

0.22

491

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.77

2.81

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

646

1.43

2.79

1.4

e6/l

1980.8

1332.4

0.13

520

(3035947) Staphylolysin Ab [Units/volume] in Serum

144

1.95

2.79

1.2

1.1

iu/ml

—

4.3

—

(3000060) B lymphocytes [#/volume] in Blood

2.47

2.78

1.6

2.0

e6/l

44.3

120.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

790

1.39

2.77

3.6

3.2

nmol/l

0.8

1.42

603

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

254

1.70

2.77

1.3

1.1

—

63.8

—

(3037121) Protein [Mass/volume] in Urine

150

1145

1.32

2.74

3.4

3.0

g/l

0.4

0.3

0.56

436

(4306422)

419

1.54

2.74

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

2.20

2.73

1.4

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

263

1.68

2.72

1.3

1.2

—

53.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

444

1.52

2.72

7.9

6.6

mg/l

12.6

12.2

0.35

414

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.37

2.72

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

713

0.61

2.72

3.1

3.7

mg/l

23.7

27.1

0.33

439

(3017181) Myelocytes/100 leukocytes in Blood

329

2761

1.21

2.71

4.9

4.0

1.1

0.9

0.66

800

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

561

4933

1.16

2.68

3.2

ug/l

0.8

0.13

419

3407

(3044290) Cell count panel - Cerebral spinal fluid

593

1.44

2.68

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.28

2.67

1.7

1.5

g/l

20.3

26.5

0.58

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

2.64

1.0

1.4

—

(3022313) Gas panel - Capillary blood

187

1479

1.28

2.64

3.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

128

962

1.34

2.62

1.3

iu/l

36.1

0.00

110

829

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

107

782

1.38

2.61

1.4

1.2

u/ml

1.8

6.9

—

(3044941) Cell count panel - Synovial fluid

539

1.46

2.60

1.6

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.15

2.55

1.0

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

7.15

2.55

1.4

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.43

2.53

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

355

1.56

2.53

1.3

1.4

mosm/kgh2o

278.2

277.5

0.06

273

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

269

1.64

2.53

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

2.09

2.52

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

2067

1.23

2.51

3.8

3.7

kpa

5.0

5.2

1.74

232

1908

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

396

1.52

2.51

1.5

63.3

60.0

0.28

247

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

240

1.67

2.47

1.3

1.2

—

4.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.67

2.45

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

107

792

1.36

2.44

1.4

1.2

u/ml

1.8

7.8

2.33

139

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

249

1.65

2.43

1.3

1.6

—

(3009343) pH of Capillary blood

247

2039

1.23

2.42

3.8

3.7

7.4

0.10

266

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.95

2.41

1.0

—

(3045424) Erythrocytes [Presence] in Urine

557

1.43

2.39

1.9

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

305

1.58

2.38

1.3

1.4

u/l

215.2

305.2

1.34

298

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

238

1963

1.23

2.36

3.7

3.6

mmol/l

1.5

2.0

1.35

184

1467

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

125

1.93

2.35

4.5

2.4

—

(3045788) Cell count panel - Pleural fluid

339

1.54

2.32

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

200

1.71

2.28

7.5

6.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

381

1.50

2.28

1.4

e6/l

19075.2

74948.0

1.58

220

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

159

1260

1.27

2.26

3.9

mmol/l

24.9

0.02

143

1155

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.28

2.24

5.0

7.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

336

1.53

2.19

3.5

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

320

1.54

2.19

1.1

u/ml

0.8

1.4

0.56

127

(3025315) Body weight

3.34

2.18

4.1

4.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

136

1.84

2.17

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

158

1.78

2.17

3.9

3.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

4.29

2.15

1.0

u/ml

0.0

0.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.29

2.15

2.0

3.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.69

2.15

2.3

1.3

nmol/l

58.3

3.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

332

1.51

2.08

1.3

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

431

1.45

2.07

1.5

e6/l

1404.1

2027.0

0.85

317

(3004616) Nuclear Ab [Presence] in Serum

391

1.46

2.04

1.5

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

475

1.42

2.02

1.5

g/l

29.7

31.7

0.56

435

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.11

2.02

3.0

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

216

1.63

2.00

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

393

1.46

1.99

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

753

1.32

1.95

2.4

2.2

g/l

122.5

126.9

0.79

538

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.55

1.94

5.2

5.1

umol/l

411.0

365.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

127

1.82

1.93

2.0

2.4

—

31.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

1.52

1.92

1.2

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

258

1.56

1.92

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

121

1.82

1.88

1.0

—

(40761536) Microorganisms panel - Urine sediment

226

2662

0.84

1.81

5.6

4.2

—

(3025159) Blasts/100 leukocytes in Blood

286

2467

1.17

1.81

4.8

4.1

0.0

0.4

1.17

624

(3028707) Methadone [Presence] in Urine by Screen method

191

1.63

1.80

1.3

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

862

1.28

1.77

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

759

1.30

1.73

1.9

1.8

iu/l

152.3

4.4

0.50

255

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

381

1.42

1.71

1.1

u/ml

1.1

1.9

0.45

150

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

3.85

1.71

1.6

1.9

mg/l

2.1

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

170

1409

1.22

1.69

1.8

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.10

1.65

1.5

—

(3000285) Sodium [Moles/volume] in Blood

2.25

1.63

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

1.65

1.62

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.87

1.60

1.4

36.3

30.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

1247

1.22

1.57

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.82

1.57

1.1

1.2

g/l

35.3

39.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.20

1.57

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

1.61

1.55

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.61

1.55

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

298

1.45

1.53

1.3

1.4

31.3

31.4

0.01

184

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.83

1.51

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

503

1.34

1.51

1.6

1.7

nmol/l

40.0

43.4

0.79

478

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.86

1.50

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.86

1.50

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.90

1.49

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

186

1.56

1.48

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.81

1.47

1.1

—

(3011288) Drugs identified in Urine by Screen method

276

1.45

1.46

1.6

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

377

1.38

1.46

1.2

—

(3000012) Reticulocyte production index

187

1.56

1.45

1.3

1.6

—

(3000330) Specific gravity of Urine by Test strip

203

1739

1.18

1.45

4.5

3.7

—

(3023410) Appearance of Cerebral spinal fluid

286

1.44

1.43

1.4

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

329

1.40

1.4

mmol/l

6.5

6.7

0.14

312

(3035880) pH of Pleural fluid

197

1.53

1.40

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

793

1.26

1.39

1.4

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.42

1.39

1.6

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

296

2619

1.14

1.38

4.9

4.1

0.1

0.17

736

(4027681)

150

1.60

1.37

1.2

—

(3004451) EKG impression Narrative

182

1.54

1.37

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.20

1.37

1.8

2.4

—

(3045142) Bone marrow Pathology biopsy report

391

1.36

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

609

1.29

1.36

1.5

1.2

u/ml

15.9

47.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

426

1.34

1.35

1.9

1.6

—

(3008898) HLA-B27 [Presence]

105

851

1.24

1.34

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.15

1.33

1.9

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

173

2021

0.85

1.32

2.0

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

108

880

1.23

1.32

5.4

4.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

384

3468

1.12

1.30

3.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

1.66

1.30

1.3

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

369

1.36

1.29

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

614

1.28

1.29

3.8

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.78

1.28

1.8

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

439

1.33

1.27

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.79

1.27

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.22

1.24

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.22

1.24

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.22

1.24

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

399

1.33

1.22

1.3

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

112

926

1.22

1.9

1.7

mg/l

8.3

3.6

1.24

678

(3002179) Metamyelocytes/100 leukocytes in Blood

282

2514

1.13

1.20

4.1

3.9

0.7

0.6

0.13

573

(3024263) Appearance of Synovial fluid

180

1.50

1.20

1.6

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

223

1.44

1.16

1.2

mmol/l

1.9

2.2

0.85

209

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.1

—

10.4

—

(3012441) Differential panel - Pleural fluid

351

1.34

1.15

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.05

1.15

2.5

1.7

umol/l

48.6

42.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.75

1.12

1.1

1.8

ug/l

1.9

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.12

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.12

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.12

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.90

1.12

4.8

7.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

111

1.62

1.12

1.3

2.4

umol/l

88.0

163.1

0.90

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

1.56

1.11

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.71

1.11

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.96

1.11

1.2

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.26

1.10

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

160

1.50

1.09

1.3

1.2

ratio

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.19

1.08

1.1

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.65

1.06

1.8

1.6

ug/l

0.4

—

(3027944) Amphetamines [Presence] in Urine

427

1.29

1.05

1.3

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

136

1164

1.17

1.05

1.6

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

1.05

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.71

1.05

1.2

1.0

—

(3019225) pH of Specimen

386

3536

1.10

1.04

5.0

4.4

—

(4015189)

1.67

1.04

5.3

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.27

1.03

1.6

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.96

1.03

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.06

1.02

1.0

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

138

1.52

1.02

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.89

1.01

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

290

1.35

1.01

4.7

3.1

mg/l

155.7

32.2

1.05

215

(3028433) Virus identified in Specimen by Culture

107

1.59

0.99

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

189

1.43

0.99

2.1

2.0

e9/l

0.2

0.02

180

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.71

0.98

1.1

umol/24h

0.8

0.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

133

0.53

0.98

2.3

5.4

—

56.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

101

849

1.19

0.97

3.6

3.3

mmol/l

23.8

25.1

2.71

737

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.62

0.93

1.8

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.22

0.93

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

374

1.29

0.92

1.8

1.6

—

(3014271) Vancomycin [Susceptibility]

192

1.41

0.92

3.8

2.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

201

1.40

0.91

1.4

promille

0.6

1.1

1.01

154

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

236

1.36

0.89

1.1

1.0

ng/l

380.9

334.8

0.32

148

(3047189) Immunofixation for 24 hour Urine

168

1.43

0.89

1.7

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.91

0.88

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

237

1.35

0.87

1.1

1.0

ng/l

752.7

687.9

0.34

147

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.86

0.87

1.4

1.0

—

(1002224) Polysomnography panel

120

1039

1.16

0.85

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

433

1.25

0.84

1.3

1.7

—

(3027008) Opiates [Presence] in Urine

433

1.25

0.84

1.3

1.7

—

(4268621)

291

1.31

0.84

2.2

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.63

0.84

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.63

0.84

2.2

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.78

0.84

1.3

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

239

1.34

0.84

1.1

1.0

ng/l

46.6

47.0

0.02

147

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

274

1.32

0.83

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.88

0.81

1.2

1.1

—

(4212803)

1.88

0.81

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

302

1.29

0.81

1.1

—

3.2

—

(3028300) Cannabinoids [Presence] in Urine

436

1.24

0.80

1.3

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.70

0.80

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

1.38

0.79

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.82

0.79

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

1.4

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

173

1.39

0.78

21.1

12.5

—

(3034426) Prothrombin time (PT)

1.53

0.78

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.56

0.78

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.56

0.78

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

209

1.34

0.75

1.4

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.08

0.74

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.74

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

199

1802

1.11

0.73

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.72

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.80

0.72

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.75

0.71

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

400

0.77

0.71

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

101

1.49

0.70

1.1

miu/ml

1977.8

1654.0

0.44

101

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.71

0.70

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

118

1.44

0.69

1.1

2.0

ug/l

3.9

6.0

—

(3025130) Human papilloma virus identified in Specimen

328

1.25

0.69

1.6

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.85

0.68

1.0

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.85

0.68

1.0

1.1

u/ml

0.0

3.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.67

0.68

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.54

0.65

1.3

2.0

—

(4281824)

404

1.22

0.64

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.73

0.64

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.64

2.2

2.7

u/field

0.4

0.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.60

0.61

1.3

1.1

—

(4024509)

357

0.78

0.61

1.6

1.7

—

(40758358) Immune stain study

0.00

0.60

0.0

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

175

0.68

0.60

1.8

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

175

0.68

0.60

1.8

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

175

0.68

0.60

1.8

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

175

0.68

0.60

1.8

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

565

1.17

0.59

4.1

3.6

1.3

1.5

0.31

435

(3010726) Horse dander IgE Ab [Units/volume] in Serum

291

1.24

0.58

1.1

1.0

u/ml

1.4

1.9

0.19

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

255

1.26

0.58

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

267

2865

0.93

0.58

4.6

3.9

mmol/l

1.2

0.87

239

2480

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.46

0.58

1.4

15.6

21.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

106

1.42

0.57

1.5

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

158

1.33

0.57

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

185

1.30

0.56

1.3

1.2

mmol/l

9.6

12.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

203

1.28

0.55

1.5

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.45

0.55

1.1

—

(3012501) Base excess in Blood by calculation

759

1.14

0.53

4.0

4.6

mmol/l

2.7

2.8

0.09

534

(3005011) Chlamydia sp Ab [Titer] in Serum

1.54

0.53

1.7

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.61

0.52

1.0

1.4

—

1742191.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.41

0.51

1.0

1.1

—

(4146454)

379

1.19

0.51

3.0

2.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.46

0.50

7.8

7.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

1.31

0.50

1.2

1.6

—

(1616796) Gas panel - Central venous blood

754

1.13

0.50

3.8

3.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

726

1.13

0.49

2.9

kpa

8.3

8.0

0.92

671

(3048879) Bone marrow aspiration report

101

1.39

0.49

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.56

0.49

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.52

0.48

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

109

985

1.11

0.48

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

143

0.70

0.47

1.8

1.4

—

(3005033) Fetal Nuchal fold Thickness US

143

0.70

0.47

1.8

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

177

0.73

0.47

2.8

2.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

346

1.19

0.46

4.6

3.5

61.8

58.5

0.41

220

(3014891) Appearance of Pleural fluid

1.43

0.46

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

120

1314

0.91

0.45

1.6

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

302

1.19

0.44

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.61

0.43

1.0

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1.30

0.42

1.1

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

0.75

0.42

3.0

4.3

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.41

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

5.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

159

1.26

0.40

1.5

1.4

—

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

241

1.20

0.40

1.2

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

0.74

0.40

1.7

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

232

1.21

0.39

1.0

1.1

u/ml

0.8

3.0

1.53

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.34

0.39

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

170

1.24

0.37

2.6

2.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

125

1.28

0.37

1.9

2.0

—

(3015183) Erythrocyte sedimentation rate

125

1.28

0.37

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

563

1.12

0.36

1.2

—

(3021901) Oxygen saturation in Capillary blood

623

1.11

0.34

3.1

2.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

321

1.15

0.33

1.5

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.70

0.33

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

201

1.20

0.32

1.1

1.0

u/ml

0.1

0.3

0.86

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.35

0.31

1.3

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

277

1.16

0.30

1.7

1.5

u/ml

36.0

19.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

114

1222

0.93

0.30

1.6

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

362

1.13

0.30

5.1

4.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

111

1.26

0.30

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

288

1.15

0.29

1.8

1.5

nmol/l

0.2

0.3

0.77

206

(40765096) Chromosome analysis panel by Banding

112

1.25

0.28

1.4

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

1.26

0.28

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.32

0.28

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.29

0.28

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

537

1.10

0.27

2.0

1.9

mmol/l

1.8

1.7

0.32

522

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.23

0.27

1.3

—

(3017569) Oxygen content in Arterial blood

168

1.19

0.27

2.6

2.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.21

0.26

1.5

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

1.25

0.26

1.9

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

182

0.82

0.26

1.7

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.28

0.26

1.4

1.2

ug/l

2.2

410.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

127

0.79

0.25

12.1

11.9

nmol/l

949.4

857.7

—

122

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

330

1.12

0.25

1.3

mmol/l

7.6

7.7

0.12

236

(3033705) Calcium.ionized [Moles/volume] in Venous blood

426

1.10

0.24

3.0

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

137

0.80

0.24

1.6

1.5

—

(3016228) CD19 cells/100 cells in Blood

133

1.20

0.24

1.9

2.0

9.3

8.2

0.11

125

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

133

1.20

0.24

1.8

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

437

1.10

0.23

3.0

2.4

mmol/l

106.2

105.2

1.06

432

(3041354) Potassium [Moles/volume] in Venous blood

437

1.10

0.23

3.0

2.4

mmol/l

4.1

0.36

432

(3027923) C peptide [Moles/volume] in Serum or Plasma

171

1.17

0.23

1.3

nmol/l

1.5

1.2

0.77

133

(3009015) Lactate [Moles/volume] in Synovial fluid

1.28

0.23

1.0

1.3

—

6.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.76

0.22

2.7

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.76

0.22

2.7

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.76

0.22

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

153

1.18

0.22

1.3

1.4

8.2

3.6

—

(3020491) Glucose [Moles/volume] in Blood

229

1.14

0.21

2.3

2.5

mmol/l

7.4

6.9

0.50

148

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.19

0.21

1.2

1.1

umol/24h

1.8

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.5

—

3.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

14.3

—

(3010421) pH of Blood

895

1.06

0.21

4.1

4.3

7.4

0.04

746

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

12.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

1426

0.95

0.21

2.2

1.9

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.24

0.21

1.0

1.2

—

20.7

—

(3042631) Mycobacterium sp identified in Specimen

479

1.09

0.20

2.2

2.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.20

0.0

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

251

1.12

0.18

1.1

1.0

u/ml

5.7

2.2

0.44

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

166

1.15

0.18

1.6

1.7

u/field

4.7

2.1

—

115

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

649

1.06

0.17

3.2

3.7

60.9

57.7

1.25

649

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.76

0.17

1.0

—

(4133840)

0.76

0.17

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

129

1.16

0.17

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.71

0.16

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.18

0.16

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

120

1.17

0.16

1.5

1.4

pmol/l

176.8

318.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

298

0.91

0.16

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.14

0.16

1.4

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

409

1.08

0.15

4.9

4.8

umol/l

364.4

358.9

0.10

351

(3020650) Glucose [Presence] in Urine

1.21

0.15

1.3

1.6

—

(3013637) Mi-2 Ab [Presence] in Serum

1.15

0.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.15

0.15

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.15

0.15

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.15

0.15

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.10

0.15

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.10

0.15

2.8

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

814

8041

1.02

0.14

4.6

3.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

131

1.15

0.14

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

131

1.15

0.14

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

1315

0.96

0.13

2.0

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

113

1.15

0.13

1.2

1.5

—

(3011648) Oxygen content in Venous blood

267

1.09

0.13

2.2

1.8

10.9

10.8

0.05

267

(40768793) Breast Pathology biopsy report

864

1.04

0.12

1.2

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.18

0.12

1.0

2.0

—

(40768795) Lymph node Pathology biopsy report

334

0.93

0.12

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

168

0.89

0.11

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

168

0.89

0.11

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

168

0.89

0.11

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

168

0.89

0.11

1.7

1.6

—

(3022806) Fractional oxyhemoglobin in Capillary blood

445

0.94

0.11

2.0

1.9

89.8

89.4

0.21

439

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

0.89

0.11

1.2

1.1

u/l

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.11

0.09

2.0

1.7

—

(44806420)

116

1.12

0.09

2.1

2.3

—

(3022621) pH of Urine by Test strip

220

2162

1.02

0.08

4.3

3.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.83

0.08

1.0

1.3

—

(3005570) Glucose [Moles/volume] in Urine

338

0.95

0.08

3.5

2.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.83

0.07

1.3

2.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1.07

0.07

1.1

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.82

0.07

1.1

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.06

0.07

2.4

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

118

1.10

0.07

2.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

334

0.96

0.05

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

334

0.96

0.05

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

1.10

0.05

1.8

u/l

9.2

65.1

1.59

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

283

0.95

0.05

1.3

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

278

1.04

0.04

1.8

2.1

u/field

4.0

2.0

—

100

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

209

1.05

0.04

1.1

—

(3045716) Anion gap in Serum or Plasma

160

1.06

0.04

1.5

1.9

mmol/l

8.1

9.4

—

127

(3019977) pH of Arterial blood

180

1.06

0.04

3.0

2.8

7.4

0.34

(40767503) Oxygen content in Capillary blood by calculation

717

0.99

0.01

3.0

2.5

16.4

15.9

0.41

370

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

198

1.01

0.00

1.1

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

785

0.99

0.00

2.1

2.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

421

4208

1.00

0.00

5.0

4.7

32.6

33.1

0.51

269

2740

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

199

1.01

0.00

1.1

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

196

1.02

0.00

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

303

0.99

0.00

3.1

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

453

0.99

0.00

1.2

1.1

iu/ml

67.3

1383.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.3

—

70.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

150.8

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1205.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.91

0.00

2.3

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.97

0.00

1.0

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.00

0.00

3.0

2.8

—

59.3

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.0

1.0

—

19.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.95

0.00

1.7

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.00

0.00

1.3

2.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_STOMACH and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_STOMACH	1.275 [1.15, 1.41]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.086

During the follow-up period (1.1.1998 — 31.12.2019), 2054 out of 10219 females with CD2_BENIGN_STOMACH died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_STOMACH	1.407 [1.25, 1.58]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 1717 out of 5767 males with CD2_BENIGN_STOMACH died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_STOMACH.

N-year risk	Females	Males
1	0.146%	0.235%
5	0.713%	1.615%
10	1.746%	4.04%
15	3.232%	7.786%
20	5.547%	13.066%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_STOMACH – Benign neoplasm: Stomach

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Stomach

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints